BN Business News
Adicionar empresa →
Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.

Negócios · 26/07/20021 min de leitura

Determination That Cyanocobalamin Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

Tradução automática local · Idioma original da fonte

Resumo

The Food and Drug Administration (FDA) has determined that cyanocobalamin injection (Rubramin PC), 1 milligram (mg)/milliliter (mL) in a 10 mL vial (cyanocobalamin injection) was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for cyanocobalamin injection.

Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →

Explorar análises

Análises empresariais →